Experienced in PEPCK 1 Deficiency

Dr. Ethan Weinberg

Hepatology
University Of Penn - Medical Group
1501 N Cedar Crest Blvd, 110 Penn Medicine Gi Transplant Lehigh Va, 
Allentown, PA 
 (1046.6 mi)
Experienced in PEPCK 1 Deficiency
University Of Penn - Medical Group
1501 N Cedar Crest Blvd, 110 Penn Medicine Gi Transplant Lehigh Va, 
Allentown, PA 
 (1046.6 mi)
OverviewInsuranceLocationsClinical Research

Overview

Ethan Weinberg is a Hepatologist in Allentown, Pennsylvania. Dr. Weinberg and is rated as an Experienced provider by MediFind in the treatment of PEPCK 1 Deficiency. His top areas of expertise are Hepatitis, Liver Failure, Hepatorenal Syndrome, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of PEPCK 1 Deficiency.

Specialties
Hepatology
Licenses
Internal Medicine in PA
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Penn Presbyterian Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna

Locations

UNIVERSITY OF PENN - MEDICAL GROUP
1501 N Cedar Crest Blvd, 110 Penn Medicine Gi Transplant Lehigh Va, Allentown, PA 18104
Other Locations
UNIVERSITY OF PENN - MEDICAL GROUP
3400 Spruce St, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Weinberg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multi-Center, Open Label, Collaborative Research Study to Treat HRS-AKI Patients With Continuous Terlipressin Infusion
A Multi-Center, Open Label, Collaborative Research Study to Treat HRS-AKI Patients With Continuous Terlipressin Infusion
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Terlipressin
Study Phase: Phase 3
A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Dose-Titration, Open-Label Study Evaluating the Safety and Efficacy of BIV201 Compared to Standard of Care to Reduce Ascites and Complications in Cirrhotic Patients With Refractory Ascites
A Phase 2 Randomized, Dose-Titration, Open-Label Study Evaluating the Safety and Efficacy of BIV201 Compared to Standard of Care to Reduce Ascites and Complications in Cirrhotic Patients With Refractory Ascites
Enrollment Status: Terminated
Publish Date: May 08, 2024
Intervention Type: Drug
Study Drug: Terlipressin Diacetate
Study Phase: Phase 2
A Single-center, Open Label, Cross-over Study on the Effects of Ursodeoxycholic Acid (UDCA) in Patients With Hepatic Sarcoidosis
A Single-center, Open Label, Cross-over Study on the Effects of Ursodeoxycholic Acid (UDCA) in Patients With Hepatic Sarcoidosis
Enrollment Status: Terminated
Publish Date: June 07, 2023
Intervention Type: Drug
Study Drug: Ursodeoxycholic acid
Study Phase: Phase 2
View 3 Less Clinical Trials

51 Total Publications

Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: May 31, 2024

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile